Entoinnov uses an insect-based bioprocess that converts agricultural by-products into superfood ingredients for humans and animals.
Entoinnov has raised $1.7M in total funding. The most recent round was Seed. The last funding was announced in October 2024.
Entoinnov's investors include Alsace Business Angels, GROUPE ILP, YEAST, I-Neo capital, Incubateur Lorrain.
Entoinnov is headquartered in Vandoeuvre-lès-nancy, France.
Entoinnov uses an insect-based bioprocess that converts agricultural by-products into superfood ingredients for humans and animals.
Entoinnov is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Entoinnov — Funding & Investors." VCBacked, October 2, 2024, https://www.vcbacked.co/company/entoinnov. Accessed August 14, 2026.
VCBacked. (2024). Entoinnov — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/entoinnov
{{cite web |title=Entoinnov — Funding & Investors |url=https://www.vcbacked.co/company/entoinnov |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated